An associate at Levy Konigsberg LLP, Michael Blom focuses on personal injury, pharmaceutical drug injury, medical device liability, and mass tort litigation. Current and past litigations include Elmiron, Zantac, firefighting foam (AFFF), Paragard IUD, valsartan, Roundup, 3M military earplugs, Truvada, breast implants, hernia mesh, hip and knee replacement implants, Essure birth control, proton pump inhibitors, talcum powder, Invokana, IVC filter, Xarelto, testosterone replacement therapy, and others.
Michael received The National Trial Lawyers: Top 40 under 40 – Civil Plaintiff recognition for 2018, 2019, and 2020, was selected to the Super Lawyers 2020 New York Metro Rising Stars list, and received a 2021 Best Lawyers: Ones To Watch recognition for Mass Tort Litigation/Class Actions – Plaintiffs, Personal Injury Litigation – Plaintiffs, and Product Liability Litigation – Plaintiffs.
Michael is admitted to the New York State Bar, Third Department, the U.S. District Court for the Southern and Eastern Districts of New York, and the U.S. Court of Appeals for the Second Circuit.
Michael is a member of the American Bar Association, the New York State Bar Association, the New York County Lawyers’ Association, and the American Association for Justice.
Michael received a Bachelor of Science degree in biological-evolutionary psychology from the Pennsylvania State University, University Park, PA in 2006. He earned a Juris Doctor degree from Nova Southeastern University, Shepard Broad College of Law, Ft. Lauderdale, FL in 2011.
During law school, Michael was a law clerk in the felony trial, misdemeanor, and non-support divisions for the Office of the Public Defender in Baltimore, MD. He was also a court liaison in the dependency division for abused, neglected, and abandoned children for Guardian ad Litem in Ft. Lauderdale, FL.